Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?

Published:2018-01 Issue: Volume:101 Page:78-88
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Chen Yuehong,Friedman Marcia,Liu Gang,Deodhar Atul,Chu Cong-Qiu

Funder

Rheumatology Research Foundation Innovative and Pilot

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference75 articles.

1. TNF-alpha signalling and inflammation: interactions between old acquaintances;Zelova;Inflammat. Res.: Official J. Eur. Histamine Res. Soc. [et al.],2013

2. The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases;Blandizzi;Int. J. Immunopathol. Pharmacol.,2014

3. Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases;Lai;Int. Immunol.,2016

4. Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases;Taylor;Curr. Opin. Pharmacol.,2010

5. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases;Willrich;Transl. Res.: J. Lab. Clin. Med.,2015

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi role ChatGPT framework for transforming medical data analysis;Scientific Reports;2024-06-17

2. Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosed in a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Association?;Indian Journal of Dermatology;2024-05

3. Skin Cancer in the Immunocompromised Patient;Rook's Textbook of Dermatology;2024-03-19

4. Case Report: Malignant melanoma in a patient with Crohn’s disease treated with ustekinumab;F1000Research;2023-10-04

5. Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials;Journal of the American Academy of Dermatology;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3